JPRN-jRCT2080224810已完成1 期
Phase I/II study of NS-87 in patients with high risk acute myeloid leukemia.
ippon Shinyaku Co., Ltd.0 个研究点目标入组 41 人开始时间: 2019年7月30日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 41
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 60age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Untreated AML patients diagnosed with therapy-related AML or AML with myelodysplasia-related changes.
排除标准
- •Patients with a diagnosis of APL or favorable cytogenetics.
- •Patients with prior treatment intended for induction therapy of AML.
研究者
相似试验
已完成
2 期
Phase II study of NS-17 in elderly patients with acute myeloid leukemia.acute myeloid leukemiaJPRN-jRCT2080223699ippon Shinyaku Co., Ltd.50
已完成
2 期
A phase 2 study of S-812217 in patients with major depressive disorderJPRN-jRCT2080225180SHIONOGI & CO., LTD.240
未知
1 期
Phase I Clinical Study of RG7167 in Patients with Advanced Solid TumorsJPRN-jRCT2080221451Chugai Pharmaceutical Co., Ltd.36
招募中
3 期
A phase 3 study of S-812217 in patients with major depressive disorderdepressionJPRN-jRCT2031210577agata Tsutae400
招募中
1 期
Phase I study of RO7187797 in patients with Multiple myeloma.Multiple myelomaJPRN-jRCT2061220045anki Toshihiro6